Coordinatore | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
Organization address
address: 101 Rue de Tolbiac contact info |
Nazionalità Coordinatore | France [FR] |
Sito del progetto | http://www.myoage.eu |
Totale costo | 14˙991˙949 € |
EC contributo | 11˙200˙000 € |
Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
Code Call | FP7-HEALTH-2007-B |
Funding Scheme | CP-IP |
Anno di inizio | 2009 |
Periodo (anno-mese-giorno) | 2009-01-01 - 2013-06-30 |
# | ||||
---|---|---|---|---|
1 |
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
Organization address
address: 101 Rue de Tolbiac contact info |
FR (PARIS) | coordinator | 1˙076˙404.00 |
2 |
REGION HOVEDSTADEN
Organization address
address: KONGENS VAENGE 2 contact info |
DK (HILLEROD) | participant | 1˙079˙708.00 |
3 |
UNIVERSITA DEGLI STUDI DI PADOVA
Organization address
address: VIA 8 FEBBRAIO 2 contact info |
IT (PADOVA) | participant | 834˙050.00 |
4 |
INSERM - TRANSFERT SA
Organization address
address: Rue Watt 7 contact info |
FR (PARIS) | participant | 790˙110.00 |
5 |
ACADEMISCH ZIEKENHUIS LEIDEN
Organization address
address: Albinusdreef 2 contact info |
NL (LEIDEN) | participant | 664˙504.00 |
6 |
THE MANCHESTER METROPOLITAN UNIVERSITY
Organization address
address: All Saints Building Oxford Road contact info |
UK (MANCHESTER) | participant | 590˙400.00 |
7 |
FONDAZIONE PER LA RICERCA BIOMEDICA AVANZATA ONLUS
Organization address
address: Via Orus Giuseppe 2 contact info |
IT (PADOVA) | participant | 589˙916.00 |
8 |
JYVASKYLAN YLIOPISTO
Organization address
address: SEMINAARINKATU 15 contact info |
FI (JYVASKYLA) | participant | 576˙960.00 |
9 |
UNIVERSIDAD POMPEU FABRA
Organization address
address: PLACA DE LA MERCE 10-12 contact info |
ES (BARCELONA) | participant | 575˙839.00 |
10 |
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA
Organization address
address: Piazzale Aldo Moro 5 contact info |
IT (ROMA) | participant | 567˙516.00 |
11 |
ALMA MATER STUDIORUM-UNIVERSITA DI BOLOGNA
Organization address
address: Via Zamboni 33 contact info |
IT (BOLOGNA) | participant | 565˙764.00 |
12 |
UNIVERSITE PIERRE ET MARIE CURIE - PARIS 6
Organization address
address: Place Jussieu 4 contact info |
FR (PARIS) | participant | 564˙640.00 |
13 |
TARTU ULIKOOL
Organization address
address: ULIKOOLI 18 contact info |
EE (TARTU) | participant | 557˙920.00 |
14 |
UNIVERSITE DE NAMUR ASBL
Organization address
address: Rue de Bruxelles 61 contact info |
BE (NAMUR) | participant | 556˙116.00 |
15 |
UPPSALA UNIVERSITET
Organization address
address: SANKT OLOFSGATAN 10 B contact info |
SE (UPPSALA) | participant | 545˙116.00 |
16 |
KAYSER ITALIA SRL
Organization address
address: Via di Popogna 501 contact info |
IT (LIVORNO) | participant | 523˙871.00 |
17 |
UNIVERSITA DEGLI STUDI DI PAVIA
Organization address
address: STRADA NUOVA 65 contact info |
IT (PAVIA) | participant | 288˙400.00 |
18 |
UNILEVER U.K. CENTRAL RESOURCES LIMITED
Organization address
address: "UNILEVER HOUSE, VICTORIA EMBANKMENT 100" contact info |
UK (LONDON) | participant | 252˙766.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'Ageing of skeletal muscle results in a progressive loss of mobility that decreases the quality of life and has major economic and social consequences for society at large. Increasing muscle weakness is a major component of muscle ageing. In the elderly muscles become atrophic (loss in muscle mass) and weaker (loss in muscle force), more susceptible to damage and consequently regenerate and recover more slowly than was the case in their youth. The challenge for FP7 is to identify the relative importance of sarcopaenia, thus proposing standards to define healthy ageing in order to identify age-related muscle weakness; secondly to identify molecular pathways which may be targeted to combat normal age related muscle weakness, and thirdly to identify therapeutic strategies to prevent muscle loss and weakness and enhance recovery following injury or immobilisation. The approaches which we will take to understand and combat muscle weakness in the aged population and improve healthspan can be defined in several steps: the collection and collation of data and samples, the assessment of physiological and functional parameters, the understanding of the various biological mechanisms involved, leading through integration to the development of strategies and their translation for the general European population. In order to develop and propose the general public with efficient countermeasures, the consortium will integrate data from genetics and epidemiology, molecular and cellular biology, physiology, biomechanics, as well as clinical and public health aspects, to ensure optimal scientific synergy from the leading European specialists and companies.'
As the population in Europe ages, a major challenge is to preserve its health and vitality. An EU-funded project studied how the body's muscles age.
"Formulating new Goals for global health, and proposing new Governance for global health that will allow the achievement of these goals"
Read MoreNormalisation of immune reactivity in old age – from basic mechanisms to clinical application
Read MoreNeurobiology and Treatment of Adolescent Female Conduct Disorder: The Central Role of Emotion Processing
Read More